ardelyx
Ardelyx is seeking a Medical Director of Pharmacovigilance to lead product safety strategies and ensure regulatory compliance across the product lifecycle. The role involves collaborating cross-functionally to manage safety data and risk mitigation efforts for innovative biopharmaceuticals. It requires extensive experience in drug safety, signal detection, and safety data analysis.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2007
Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines for patients with unmet medical needs in gastrointestinal and cardiorenal diseases. The company markets IBSRELA (tenapanor) for irritable bowel syndrome with constipation (IBS-C) and XPHOZAH for chronic kidney disease with hyperphosphatemia, while also pursuing additional pipeline programs including chronic idiopathic constipation. Headquartered in Northern California, Ardelyx is committed to delivering novel-mechanism therapies that improve outcomes for patients with GI and kidney disorders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ardelyx.
243% above the average for this role
Senior Medical Director, Pharmacovigilance and Safety
Taysha Gene Therapies
Director, Pharmacovigilance
Rigel Pharmaceutical, Inc.
Director, Drug Safety & Pharmacovigilance - Safety Scientist
Travere Therapeutics
Director, Drug Safety & Pharmacovigilance Scientist
Dyne Therapeutics
Senior Director, Medical Safety & Pharmacovigilance
Cytokinetics
Medical Director Pharmacovigilance
Jobgether